ALLO
Allogene Therapeutics, Inc.
$1.81+0.15 (9.04%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
Showing 10 of 18 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-01 | Roberts Zachary | CEO | Award | 476,190 | $2.11 | $1,004,761 | N/A | N/A |
| 2026-06-23 | 2026-06-18 | Kazam Joshua A | Director | Exercise Conversion | 47,700 | $0.00 | $0 | N/A | N/A |
| 2026-06-23 | 2026-06-18 | Mayo Stephen | Director | Award | 144,400 | $2.00 | $288,800 | N/A | N/A |
| 2026-04-23 | 2026-04-21 | Yoshiyama Annie | SVP | Sale | 9,586 | $2.31 | $22,144 | N/A | N/A |
| 2026-04-02 | 2026-03-31 | Beneski Benjamin Machinas | CTO | Sale | 2,867 | $2.50 | $7,168 | N/A | N/A |
| 2026-03-18 | 2026-03-16 | Beneski Benjamin Machinas | CTO | Sale | 4,835 | $2.47 | $11,942 | N/A | N/A |
| 2026-03-18 | 2026-03-16 | Chang David D | CEO | Sale | 47,763 | $2.47 | $117,975 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Beneski Benjamin Machinas | CTO | Sale | 7,132 | $2.60 | $18,543 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Douglas Earl Martin | SVP | Award | 539,072 | $0.00 | $0 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Yoshiyama Annie | SVP | Award | 179,691 | $0.00 | $0 | N/A | N/A |
ALLO
Director
Exercise Conversion
$0
Kazam Joshua A47,700 shares @ $0.00
Filed 2026-06-23Trade 2026-06-18
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.